Argitalpenak (22) ESTHER CORRAL LOZANO argitalpenak

2024

  1. Music therapy during weaning from mechanical ventilation in the intensive care unit: Study protocol for a randomised control trial

    Nordic Journal of Music Therapy

2019

  1. Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study

    The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 8, pp. 2289-2294

2016

  1. Ventriculostomy related infection in intensive care unit: Diagnostic criteria and related conditions

    Journal of Acute Disease, Vol. 5, Núm. 2, pp. 143-149

2015

  1. Feasibility and utility of the use of real time random safety audits in adult ICU patients: a multicentre study

    Intensive Care Medicine, Vol. 41, Núm. 6, pp. 1089-1098

2014

  1. A randomized trial of intravenous glutamine supplementation in trauma ICU patients

    Intensive Care Medicine, Vol. 40, Núm. 4, pp. 539-547

  2. Caffeine: Forms of consumption, toxicity, therapeutic effects and their use in medicine

    Caffeine: Consumption, Side Effects and Impact on Performance and Mood (Nova Science Publishers, Inc.), pp. 35-88

  3. Response to circulatory death determination in uncontrolled organ donors: A panel viewpoint

    Annals of Emergency Medicine

2013

  1. Intoxicación aguda grave por cafeína. A propósito de 2 casos con 2 cursos diferentes

    Medicina Intensiva

  2. Intraventricular hemorrhage treated with intraventricular fibrinolysis. A 10-year experience

    Medicina Intensiva, Vol. 37, Núm. 2, pp. 61-66

2011

  1. Donantes a corazon parado tipo III de Maastricht: una opcion real

    Medicina Intensiva

2010

  1. Descontaminación digestiva selectiva: repercusión en la carga de trabajo y el coste del laboratorio de microbiología y tendencias en la resistencia bacteriana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 2, pp. 75-81

  2. The key decision: Forgoing treatment or maintaining care

    Journal of Critical Care

2006

  1. Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: Evaluation of the sieving coefficient

    Blood Purification, Vol. 24, Núm. 4, pp. 347-354

2005

  1. Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 39, Núm. 5, pp. 996-1005

  2. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes

    Clinical Therapeutics, Vol. 27, Núm. 9, pp. 1444-1451

  3. Influence of renal function on the pharmacokinetics of piperacillin/ tazobactam in intensive care unit patients during continuous venovenous hemofiltration

    Journal of Clinical Pharmacology, Vol. 45, Núm. 2, pp. 168-176

  4. Meropenem and continuous renal replacement therapy: In vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients

    Journal of Clinical Pharmacology, Vol. 45, Núm. 11, pp. 1294-1304

2004

  1. Clarification regarding NMR imaging with Servo 900C ventilator

    Medicina Intensiva

2003

  1. Resonancia magnética con un Servo 900 C

    Medicina Intensiva

1997

  1. Intrapericardial streptokinase fibrinolysis in the management of purulent pneumococcal pericarditis (multiple letters) [3]

    Intensive Care Medicine